World
CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Schering-Plough will provide hepatitis C treatment to ADAP enrollees
Drugmaker Schering-Plough has announced a new program that will provide 1,500 people enrolled in state-run AIDS Drug Assistance Programs with a free full course of its experimental combination hepatitis C treatment Peg-Intron and Rebetol. The initiative, called "Commitment to Community," provides HIV-HCV coinfected ADAP clients with Peg-Intron powder for injection and Rebetol capsules to treat hepatitis C and prevent hepatitis-related liver damage and liver cancer. Hepatitis C is emerging as a leading killer of HIV-positive people, and the Centers for Disease Control and Prevention estimates that as many as 25% of all HIV-positive Americans are also coinfected with HCV. As many as 90% of HIV-positive injection drug users also carry HCV, according to the CDC.
"With current ADAP funding falling far short of meeting the demand of patients in need, this initiative with Schering-Plough is a creative solution that will yield significant savings to a system in crisis and help bring measurable relief to ADAP programs nationwide," said Julie Scofield, executive director of the National Association of State and Territorial AIDS Directors. "Providing treatment for hepatitis C treatment through ADAPs adds an additional financial burden for many state ADAPs. NASTAD's ADAP Crisis Task Force worked collaboratively with Schering-Plough to create this unique program so that we can now provide ADAP patients access to hepatitis C therapy."
The program will be administered through Schering-Plough's larger patient assistance program that provides medications to low-income Americans who can't get access to a variety of medical treatments. In addition to access to free medicine, hepatitis C patients covered by ADAP will have access to Schering-Plough's free, personalized patient support program, "Be in Charge," which offers round-the-clock toll-free telephone access to a nurse counselor and other educational tools to help patients cope with the physical and emotional impact of hepatitis C, as well as the rigors of treatment. The support program can be reached by calling (888) 437-2608 or on the Internet at www.beincharge.com. For more information about Schering-Plough's patient assistance program call (800) 521-7157.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Kamala Harris rides wave of Democratic energy at kickoff event in Wisconsin
July 23 2024 3:36 PM
'Devastated:' A six-week abortion ban will go into effect in Iowa next week
July 23 2024 2:28 PM
Four hours, 44,000 Black women, and one Zoom call
July 23 2024 2:17 PM
Record 1.2 million people show out for Cologne’s Pride parade
July 23 2024 10:51 AM
Here's how far-right activist Leonard Leo helped fund Bud Light boycott
July 23 2024 10:27 AM
Elon Musk’s comments about his trans daughter prove why she doesn’t speak to him
July 23 2024 9:16 AM
Nancy Pelosi endorses Kamala Harris for president
July 22 2024 4:07 PM
Charli XCX declares Kamala Harris IS brat & our next President's campaign agrees
July 22 2024 3:08 PM